Dierckx RA - Search Results

1

Application of (99m)Technetium-HYNIC(tricine/TPPTS)-Aca-Bombesin(7-14) SPECT/CT in prostate cancer patients: a first-in-man study.

Ananias HJ, Yu Z, Hoving HD, Rosati S, Dierckx RA, Wang F, Yan Y, Chen X, Pruim J, Lub-de Hooge MN, Helfrich W, Elsinga PH, de Jong IJ. Ananias HJ, et al. Among authors: dierckx ra. Nucl Med Biol. 2013 Oct;40(7):933-8. doi: 10.1016/j.nucmedbio.2013.05.009. Epub 2013 Jul 26. Nucl Med Biol. 2013. PMID: 23891351 Free article. Clinical Trial.

2

Comparison of sigma-ligands and metabolic PET tracers for differentiating tumor from inflammation.

van Waarde A, Jager PL, Ishiwata K, Dierckx RA, Elsinga PH. van Waarde A, et al. Among authors: dierckx ra. J Nucl Med. 2006 Jan;47(1):150-4. J Nucl Med. 2006. PMID: 16391199 Free article.

3

Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.

Slart RH, Bax JJ, van Veldhuisen DJ, van der Wall EE, Irwan R, Sluiter WJ, Dierckx RA, de Boer J, Jager PL. Slart RH, et al. Among authors: dierckx ra. Eur J Nucl Med Mol Imaging. 2006 Jun;33(6):716-23. doi: 10.1007/s00259-005-0016-z. Epub 2006 Mar 8. Eur J Nucl Med Mol Imaging. 2006. PMID: 16523309 Clinical Trial.

4

Nitrate administration increases blood flow in dysfunctional but viable myocardium, leading to improved assessment of myocardial viability: A PET study.

Slart RH, Agool A, van Veldhuisen DJ, Dierckx RA, Bax JJ. Slart RH, et al. Among authors: dierckx ra. J Nucl Med. 2006 Aug;47(8):1307-11. J Nucl Med. 2006. PMID: 16883010 Free article. Clinical Trial.

5

Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells.

van Waarde A, Been LB, Ishiwata K, Dierckx RA, Elsinga PH. van Waarde A, et al. Among authors: dierckx ra. J Nucl Med. 2006 Sep;47(9):1538-45. J Nucl Med. 2006. PMID: 16954564 Free article.

6

Detection of bone metastases in thyroid cancer patients: bone scintigraphy or 18F-FDG PET?

Phan HT, Jager PL, Plukker JT, Wolffenbuttel BH, Dierckx RA, Links TP. Phan HT, et al. Among authors: dierckx ra. Nucl Med Commun. 2007 Aug;28(8):597-602. doi: 10.1097/MNM.0b013e32822a0cb5. Nucl Med Commun. 2007. PMID: 17625381

7

Rapid reduction of sigma1-receptor binding and 18F-FDG uptake in rat gliomas after in vivo treatment with doxorubicin.

van Waarde A, Shiba K, de Jong JR, Ishiwata K, Dierckx RA, Elsinga PH. van Waarde A, et al. Among authors: dierckx ra. J Nucl Med. 2007 Aug;48(8):1320-6. doi: 10.2967/jnumed.107.042085. Epub 2007 Jul 13. J Nucl Med. 2007. PMID: 17631546 Free article.

8

Synthesis and preliminary evaluation of (S)-[11C]-exaprolol, a novel beta-adrenoceptor ligand for PET.

van Waarde A, Doorduin J, de Jong JR, Dierckx RA, Elsinga PH. van Waarde A, et al. Among authors: dierckx ra. Neurochem Int. 2008 Mar-Apr;52(4-5):729-33. doi: 10.1016/j.neuint.2007.09.009. Epub 2007 Sep 19. Neurochem Int. 2008. PMID: 17961850

9

Evaluation of [(11)C]rofecoxib as PET tracer for cyclooxygenase 2 overexpression in rat models of inflammation.

de Vries EF, Doorduin J, Dierckx RA, van Waarde A. de Vries EF, et al. Among authors: dierckx ra. Nucl Med Biol. 2008 Jan;35(1):35-42. doi: 10.1016/j.nucmedbio.2007.07.015. Epub 2007 Sep 19. Nucl Med Biol. 2008. PMID: 18158941

10

Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study.

de Vries EF, Doorduin J, Vellinga NA, van Waarde A, Dierckx RA, Klein HC. de Vries EF, et al. Among authors: dierckx ra. Nucl Med Biol. 2008 May;35(4):459-66. doi: 10.1016/j.nucmedbio.2008.01.005. Epub 2008 Apr 3. Nucl Med Biol. 2008. PMID: 18482683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page